# Calcifediol in the Treatment of COVID 19

> **NCT05819918** · — · COMPLETED · sponsor: **Maimónides Biomedical Research Institute of Córdoba** · enrollment: 728 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Calcifediol
- **DRUG:** Best available therapy

## Key facts

- **NCT ID:** NCT05819918
- **Lead sponsor:** Maimónides Biomedical Research Institute of Córdoba
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2023-04-17
- **Final completion:** 2023-04-17
- **Target enrollment:** 728 (ACTUAL)
- **Last updated:** 2023-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05819918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05819918, "Calcifediol in the Treatment of COVID 19". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05819918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*